Company Filing History:
Years Active: 2024
Title: **Inventor Yeong-In Yang: Innovating Therapeutics for Hyperproliferative Disorders**
Introduction
Yeong-In Yang is an esteemed inventor based in Gyeonggi-do, South Korea, recognized for his significant contributions to the field of therapeutics. With one patent to his name, his work focuses on addressing critical health issues through innovative compounds.
Latest Patents
Yang’s notable patent involves quinoline derivatives, which are identified as inhibitors of AXL/MER RTK (receptor tyrosine kinase) and CSF1R (colony stimulating factor 1 receptor). This invention holds great promise for the treatment of various disorders that are related to hyperfunction of these receptors. Specifically, these compounds are designed to combat hyperproliferative disorders, including types of cancer, particularly those associated with immune suppression within the tumor microenvironment, refractory cancer, and cancer metastases. They also possess potential therapeutic applications in treating inflammatory and neurodegenerative diseases.
Career Highlights
Yeong-In Yang is currently affiliated with Qurient Co., Ltd., where he applies his expertise in medicinal chemistry to advance the development of innovative treatments. His commitment to research and development has positioned him as a key player in the pharmaceutical industry, particularly in oncology and related fields.
Collaborations
Throughout his career, Yang has collaborated with several talented individuals, including Kiyean Nam and Jaeseung Kim. These partnerships further enhance the innovative spirit within his work, enabling the exploration of novel therapeutic pathways and ensuring comprehensive research outcomes.
Conclusion
Yeong-In Yang’s contributions to the development of quinoline derivatives underscore the importance of innovation in addressing complex health challenges. With his ongoing efforts at Qurient Co., Ltd., he continues to pave the way for new therapeutic solutions that may one day significantly improve patient outcomes in cancer and other critical diseases. His work exemplifies the essential role of inventors in shaping the future of medicine.